In a filing, Novavax, Inc revealed its Former Director YOUNG JAMES F acquired Company’s shares for reported $24406.0 on Apr 14 ’25. In the deal valued at $6.10 per share,4,000 shares were bought.
Then, King Rachel K. sold 4,150 shares, generating $37,435 in total proceeds. Upon selling the shares at $9.02, the Director now owns 14,770 shares.
Before that, YOUNG JAMES F sold 5,400 shares. Novavax, Inc shares valued at $43,200 were divested by the Director at a price of $8.00 per share. As a result of the transaction, YOUNG JAMES F now holds 51,760 shares, worth roughly $0.35 million.
BTIG Research initiated its Novavax, Inc [NVAX] rating to a Buy in a research note published on February 28, 2025; the price target was $19. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in late July from “a Neutral” to “an Underweight”. JP Morgan also remained covering NVAX and has increased its forecast on May 10, 2024 with a “Neutral” recommendation from previously “an Underweight” rating. BofA Securities revised its rating on May 10, 2024. It rated NVAX as “a Neutral” which previously was an “an Underperform”.
Price Performance Review of NVAX
On Monday, Novavax, Inc [NASDAQ:NVAX] saw its stock jump 0.52% to $6.70. Over the last five days, the stock has gained 11.56%. Novavax, Inc shares have fallen nearly -16.60% since the year began. Nevertheless, the stocks have risen 61.57% over the past one year. While a 52-week high of $23.86 was reached on 01/07/25, a 52-week low of $3.92 was recorded on 04/10/25. SMA at 50 days reached $7.21, while 200 days put it at $9.87.
Levels Of Support And Resistance For NVAX Stock
The 24-hour chart illustrates a support level at 6.46, which if violated will result in even more drops to 6.21. On the upside, there is a resistance level at 7.15. A further resistance level may holdings at 7.60. The Relative Strength Index (RSI) on the 14-day chart is 49.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.42, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 39.46%. Stochastics %K at 64.46% indicates the stock is a holding.
How much short interest is there in Novavax, Inc?
A steep rise in short interest was recorded in Novavax, Inc stocks on 2025-04-15, growing by 3.48 million shares to a total of 41.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 37.55 million shares. There was a rise of 8.47%, which implies that there is a positive sentiment for the stock.
